Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on April 3

Core Insights - Nexalin Technology, Inc. is hosting a webinar on April 3, 2025, to discuss its clinical data and advancements in neurostimulation technology [1][2] - The company is focusing on its non-invasive deep brain stimulation device, which has shown effectiveness in treating conditions like insomnia, PTSD, and traumatic brain injuries, addressing a significant market need [2] - The mental health market is projected to grow substantially, reaching $537 billion by 2030, positioning Nexalin as a potential leader in this space [2] Company Overview - Nexalin designs and develops innovative neurostimulation products aimed at addressing the global mental health crisis [4] - The company's products are non-invasive and utilize bioelectronic medical technology to target deep brain structures associated with mental health disorders [4] - The Nexalin Gen-2 15 milliamp neurostimulation device has received approval in China, Brazil, and Oman, indicating its international market presence [4]